Keyphrases
Nanoparticles
100%
Head-and-neck Cancer
100%
Tumor Microenvironment
100%
Epidermal Growth Factor Receptor
100%
Receptor Targets
100%
Cas9 Protein
100%
Cancer Suppression
100%
Gene Editing
100%
Anthracycline Therapy
100%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
66%
Epirubicin
66%
SAS Cell
66%
Tumor-bearing Mice
33%
High Incidence
16%
Poor Prognosis
16%
PH Value
16%
Apoptosis
16%
PH-sensitive
16%
Spatiotemporal
16%
Cancer Cell Death
16%
Metastasis
16%
Low Cytotoxicity
16%
Cancer Treatment
16%
Chemotherapy
16%
Tumor Progression
16%
Catenin
16%
Editing System
16%
Endosomal Escape
16%
Efficient Delivery
16%
Transfection Efficiency
16%
Tumor Invasion
16%
Multifunctional Nanoparticles
16%
Mammalian Target of Rapamycin (mTOR)
16%
Targeting Ligands
16%
RNA-binding Protein
16%
Co-treatment
16%
Targeting Peptide
16%
Acidic pH
16%
Cell Transfection
16%
Cellular Uptake Efficiency
16%
Autophagy
16%
Topoisomerase Inhibitors
16%
CRISPR/Cas9 Genome Editing
16%
Nuclear Localization
16%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
16%
Human Tongue
16%
Oral Keratinocytes
16%
PH Response
16%
PH-responsive Nanoparticles
16%
Epithelial-mesenchymal Transition Pathway
16%
Necroptosis
16%
Anthracyclines
16%
Tumor Survival
16%
ELAVL1
16%
Tumor Resistance
16%
Ligand-mediated Endocytosis
16%
Tumor pH
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Tumor Microenvironment
100%
Epidermal Growth Factor Receptor
100%
Head and Neck Cancer
100%
Anthracycline
100%
Neoplasm
50%
Epirubicin
50%
Malignant Neoplasm
25%
Chemotherapy
12%
Tumor Growth
12%
RNA Binding Protein
12%
DNA Topoisomerase Inhibitor
12%
Squamous Cell Carcinoma
12%
Catenin
12%
Cytotoxicity
12%